Search Results

Gene Expression Profiles of Intracellular and Membrane Progesterone Receptor Isoforms in the Mediobasal Hypothalamus During Pro-Oestrus

Authors: Liu, B.; Arbogast, L. A.

Source: Journal of Neuroendocrinology, Volume 21, Number 12, December 2009 , pp. 993-1000(8)

Publisher: Blackwell Publishing

The Interaction of Reward Genes With Environmental Factors in Contribution to Alcoholism in Mexican Americans

Authors: Du, Yanlei; Wan, Yu-Jui Yvonne

Source: Alcoholism Clinical and Experimental Research, Volume 33, Number 12, December 2009 , pp. 2103-2112(10)

Publisher: Blackwell Publishing

Regulation of striatal nitric oxide synthesis by local dopamine and glutamate interactions

Authors: Park, Diana J.; West, Anthony R.

Source: Journal of Neurochemistry, Volume 111, Number 6, December 2009 , pp. 1457-1465(9)

Publisher: Blackwell Publishing

Inactivation of neuronal forebrain A_2A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease

Authors: Carta, Anna R.; Kachroo, Anil; Schintu, Nicoletta; Xu, Kui; Schwarzschild, Michael A.; Wardas, Jadwiga; Morelli, Micaela

Source: Journal of Neurochemistry, Volume 111, Number 6, December 2009 , pp. 1478-1489(12)

Publisher: Blackwell Publishing

Urinary Dopamine Excretion and Renal Responses to Fenoldopam Infusion in Blacks and Whites

Authors: Weder, Alan B.; Gleiberman, Lillian; Sachdeva, Amit

Source: The Journal of Clinical Hypertension, Volume 11, Number 12, December 2009 , pp. 707-712(6)

Publisher: Blackwell Publishing

Neuroprotective effects of pramipexole against tunicamycin-induced cell death in PC12 cells

Authors: Nakayama, Hitoshi; Zhao, Jing; EI-FAKhrany, Amany; Isosaki, Minoru; Satoh, Hiroyasu; Kyotani, Yoji; Yoshizumi, Masanori

Source: Clinical and Experimental Pharmacology and Physiology, Volume 36, Number 12, December 2009 , pp. 1183-1185(3)

Publisher: Blackwell Publishing

Drugs in the medical treatment of Cushing's syndrome

Author: Schteingart, David E

Source: Expert Opinion on Emerging Drugs, Volume 14, Number 4, December 2009 , pp. 661-671(11)

Publisher: Informa Healthcare

Adverse Endocrine and Metabolic Effects of Psychotropic Drugs: Selective Clinical Review

Authors: Bhuvaneswar, Chaya G.; Baldessarini, Ross J.; Harsh, Veronica L.; Alpert, Jonathan E.

Source: CNS Drugs, Volume 23, Number 12, 1 December 2009 , pp. 1003-1021(19)

Publisher: Adis International

Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Preliminary, Single-Blind, Prospective Study

Authors: Pallanti, Stefano; Bernardi, Silvia; Antonini, Sarah; Singh, Nikhilesh; Hollander, Eric

Source: CNS Drugs, Volume 23, Number 12, 1 December 2009 , pp. 1047-1055(9)

Publisher: Adis International

Reduced Adverse Event Profile of Orally Inhaled DHE (MAP0004) vs IV DHE: Potential Mechanism

Authors: Cook, Robert O.; Shrewsbury, Stephen B.; Ramadan, Nabih M.

Source: Headache: The Journal of Head and Face Pain, Volume 49, Number 10, November/December 2009 , pp. 1423-1434(12)

Publisher: Blackwell Publishing

The membrane cytoskeletal protein adducin is phosphorylated by protein kinase C in D1 neurons of the nucleus accumbens and dorsal striatum following cocaine administration

Authors: Lavaur, Jérémie; Mineur, Yann S.; Picciotto, Marina R.

Source: Journal of Neurochemistry, Volume 111, Number 5, December 2009 , pp. 1129-1137(9)

Publisher: Blackwell Publishing

The M₅ muscarinic receptor as possible target for treatment of drug abuse

Author: Raffa, R. B.

Source: Journal of Clinical Pharmacy & Therapeutics, Volume 34, Number 6, December 2009 , pp. 623-629(7)

Publisher: Blackwell Publishing

Signal Transduction via Cannabinoid Receptors

Authors: Dalton, George D.; Bass, Caroline E.; Van Horn, Cynthia G.; Howlett, Allyn C.

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 422-431(10)

Publisher: Bentham Science Publishers

Glutamate Receptors as Therapeutic Targets for Parkinson's Disease

Authors: Johnson, Kari A.; Conn, P. J.; Niswender, Colleen M.

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 475-491(17)

Publisher: Bentham Science Publishers

Established therapies and novel targets in the treatment of Parkinson's disease

Authors: Dézsi, Livia; Vécsei, László

Source: Expert Review of Clinical Pharmacology, Volume 2, Number 6, November 2009 , pp. 631-644(14)

Publisher: Expert Reviews

Translating 5-HT₄ receptor pharmacology

Author: sanger, g. j.

Source: Neurogastroenterology and Motility, Volume 21, Number 12, December 2009 , pp. 1235-1238(4)

Publisher: Blackwell Publishing

The role of dopamine in bipolar disorder

Authors: Cousins, David A; Butts, Kelly; Young, Allan H

Source: Bipolar Disorders, Volume 11, Number 8, December 2009 , pp. 787-806(20)

Publisher: Blackwell Publishing

Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect

Authors: Mann, Liad; Heldman, Eliahu; Bersudsky, Yuly; Vatner, Stephen F; Ishikawa, Yoshihiro; Almog, Orna; Belmaker, Robert H; Agam, Galila

Source: Bipolar Disorders, Volume 11, Number 8, December 2009 , pp. 885-896(12)

Publisher: Blackwell Publishing

Control of within-binge cocaine-seeking by dopamine and glutamate in the core of nucleus accumbens

Authors: Suto, Nobuyoshi; Ecke, Laurel; Wise, Roy

Source: Psychopharmacology, Volume 205, Number 3, August 2009 , pp. 431-439(9)

Publisher: Springer

Targeting murine heart and brain: visualisation conditions for multi-pinhole SPECT with ^99mTc- and ¹²³I-labelled probes

Authors: Pissarek, M.; Meyer-Kirchrath, J.; Hohlfeld, T.; Vollmar, S.; Oros-Peusquens, A.; Flögel, U.; Jacoby, C.; Krügel, U.; Schramm, N.

Source: European Journal of Nuclear Medicine and Molecular Imaging, Volume 36, Number 9, September 2009 , pp. 1495-1509(15)

Publisher: Springer